Showing results (1-10 of 509) with videos related to
Sort By:
Pageof 51
Expert Opinion on Investigational Drugs|July 2, 2003
Thiazolidinediones -- some recent developmentsMichael StumvollDiabetes|July 30, 2002
The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphismMichael Stumvoll, Hans HäringBest Practice & Research. Clinical Endocrinology & Metabolism|November 29, 2005
Fatty acids and insulin resistance in muscle and liverPeter Kovacs, Michael StumvollCurrent Opinion in Clinical Nutrition and Metabolic Care|June 15, 2007
The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes riskAnke Tönjes, Michael StumvollAnnals of Medicine|August 14, 2002
Glitazones: clinical effects and molecular mechanismsMichael Stumvoll, Hans-Ulrich HäringObesity (Silver Spring, Md.)|February 23, 2008
Brain activity in hunger and satiety: an exploratory visually stimulated FMRI studyDagmar Führer, Stefan Zysset, Michael StumvollExpert Review of Endocrinology & Metabolism|October 7, 2018
Oral antidiabetic agents: how much kidney disease can we tolerate?Christof Mayer, Andreas Holstein, Michael StumvollCurrent Pharmaceutical Design|April 8, 2010
Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver diseaseAnke Tönjes, Matthias Blüher, Michael StumvollBiochimie|December 14, 2004
Adiponectin, obesity, and cardiovascular diseaseMathias Fasshauer, Ralf Paschke, Michael StumvollPageof 51